Target intelligence / Profile preview

mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

The mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo represent a diverse set of transcripts regulated by the paracrine activity of stem cells. BMSCs secrete microvesicles that encapsulate a specific profile of microRNAs (miRNAs), which are then delivered to target cells to modulate their biological response (Source: PMC5835590). Upon entry into recipient cells, these miRNAs typically bind to the 3' untranslated regions (UTRs) of specific mRNAs, leading to gene silencing through mRNA degradation or translational inhibition (Source: Nature Reviews Genetics, 2018). This regulatory axis is a primary mechanism by which BMSC-based therapies exert anti-inflammatory, anti-apoptotic, and pro-regenerative effects in diseases such as myocardial infarction, acute kidney injury, and various cancers (Source: Stem Cell Research & Therapy, 2020). Because the term refers to a variable collection of downstream effectors rather than a single protein or nucleic acid sequence, it is characterized as a functional category of targets rather than a discrete therapeutic target. The therapeutic utility of this axis depends on the specific miRNA-mRNA interactions, which are being explored for their potential in precision regenerative medicine.

Other names
BMSC-MV miRNA targetsBMSC-EV miRNA targetsDownstream mRNA targets of BMSC-derived microvesiclesBMSC-MV miRNA-regulated genes
02

Mechanism of action

MicroRNAs within the microvesicles bind to the 3' untranslated regions (UTRs) of target mRNAs, leading to mRNA cleavage, destabilization, or inhibition of translation via the RNA-induced silencing complex (RISC).

03

Biological functions

Post-transcriptional regulationGene silencingCell-to-cell communicationSignal transduction
04

Disease associations

InflammationTissue injuryCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Off-target gene silencingHeterogeneity of BMSC-MV cargoPotential for pro-tumorigenic effects in certain contextsImmunogenicity of the delivery vehicle
06

Interacting drugs

Mesenchymal stem cell-derived extracellular vesicles
07

Biomarkers

Differential mRNA expression levelsmiRNA expression profiles in BMSC-MVsRecipient cell transcriptomic changes

Beyond the preview

Go deeper on mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call